Experimental type 1 diabetes metabolically rejuvenates CD8+ T cells for improved control of tumor growth through an IGF1-IGF1R axis

No abstract is available for this paper.

• Publication year

  2024

• Venue

  bioRxiv

• Publication date

  2024-04-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/2024.04.04.588206
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Terminally exhausted CD8+ T cells resistant to PD-1 blockade promote generation and maintenance of aggressive cancer stem cells.

  2023cited by this paper
• cis-B7:CD28 interactions at invaginated synaptic membranes provide CD28 co-stimulation and promote CD8+ T cell function and anti-tumor immunity.

  2023cited by this paper
• Immune checkpoint inhibitors related respiratory disorders in patients with lung cancer: A meta-analysis of randomized controlled trials

  2023cited by this paper
• Analysis of detrended fluctuation function derived from continuous glucose monitoring may assist in distinguishing latent autoimmune diabetes in adults from T2DM

  2022cited by this paper
• Induction of Type I Diabetes Mellitus in Beagle Dogs Using Alloxan and Streptozotocin

  2022cited by this paper
• Intensive fasting reduces thrombosis and improves innate immunity

  2022cited by this paper
• Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysis

  2022cited by this paper
• Decreased GLUT2 and glucose uptake contribute to insulin secretion defects in MODY3/HNF1A hiPSC-derived mutant β cells

  2021cited by this paper
• Immune Checkpoint Inhibitor-Induced Diabetes Mellitus: Potential Role of T Cells in the Underlying Mechanism

  2021cited by this paper
• Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets

  2021cited by this paper
• Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study.

  2021cited by this paper
• CAR-T cell therapy: current limitations and potential strategies

  2021cited by this paper
• An observational study of drug utilization and associated outcomes among adult patients diagnosed with BRAF‐mutant advanced melanoma treated with first‐line anti‐PD‐1 monotherapies or BRAF/MEK inhibitors in a community‐based oncology setting

  2020cited by this paper
• CD8+ T cell states in human cancer: insights from single-cell analysis

  2020cited by this paper
• Cytotoxic CD8+ T cells in cancer and cancer immunotherapy

  2020cited by this paper
• Insulin-Like Growth Factors Are Key Regulators of T Helper 17 Regulatory T Cell Balance in Autoimmunity.

  2020cited by this paper
• Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression.

  2019cited by this paper
• Effect of Insulin-Like Growth Factor-1 on Diabetic Retinopathy in Pubertal Age Patients With Type 1 Diabetes

  2019cited by this paper
• Metabolic Profiling Using Stable Isotope Tracing Reveals Distinct Patterns of Glucose Utilization by Physiologically Activated CD8+ T Cells.

  2019cited by this paper
• Circulating myeloid‐derived suppressor cells: An independent prognostic factor in patients with breast cancer

  2018cited by this paper
• A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer.

  2018cited by this paper
• Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions

  2018influential reference
• Early changes in the metabolic profile of activated CD8+ T cells

  2016cited by this paper
• Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals

  2016cited by this paper
• GLUT2, glucose sensing and glucose homeostasis

  2015cited by this paper
• Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity

  2015cited by this paper
• Insulin/Insulin-Like Growth Factors in Cancer: New Roles for the Aryl Hydrocarbon Receptor, Tumor Resistance Mechanisms, and New Blocking Strategies

  2015cited by this paper
• Streptozotocin‐Induced Diabetic Models in Mice and Rats

  2015cited by this paper
• Glucose Metabolism Regulates T Cell Activation, Differentiation, and Functions

  2014cited by this paper
• Streptozotocin-Induced Diabetes Models: Pathophysiological Mechanisms and Fetal Outcomes

  2014cited by this paper
• Streptozotocin–nicotinamide-induced diabetes in the rat. Characteristics of the experimental model

  2012cited by this paper
• The streptozotocin-induced diabetic nude mouse model: differences between animals from different sources.

  2011cited by this paper
• High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling

  2011cited by this paper
• Diabetes and Cancer: A Consensus Report

  2010cited by this paper
• Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells

  2008cited by this paper
• Aberrant Expression of the Insulin-Like Growth Factor-1 Receptor by T Cells from Patients with Graves’ Disease May Carry Functional Consequences for Disease Pathogenesis1

  2007cited by this paper
• Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women.

  2007cited by this paper
• Role of insulin/insulin-like growth factor 1 signaling pathway in longevity.

  2005cited by this paper
• Autoreactive CD8 T cells associated with β cell destruction in type 1 diabetes

  2005cited by this paper
• The paradox of the insulin/IGF-1 signaling pathway in longevity.

  2004cited by this paper
• Transcriptome and proteome expression in activated human CD4 and CD8 T-lymphocytes.

  2004cited by this paper
• The role of T-cells in the pathogenesis of Type 1 diabetes: From cause to cure

  2003cited by this paper
• Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice.

  1999cited by this paper
• Influence of insulin deprivation on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats subjected to alloxan diabetes and food restriction.

  1972cited by this paper

• No citing papers are available for this paper.